SIRIPS PHARMA PRIVATE LIMITED
SIRIPS PHARMA PRIVATE LIMITED is a ANDHRA PRADESH based PRIVATE LIMITED company, Registered at dated 11-MAY-2015 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of SIRIPS PHARMA PRIVATE LIMITED is U24233TG2015PTC098852 and registration number is 098852.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies HYDERABAD India. Authorized share capital of SIRIPS PHARMA PRIVATE LIMITED is Rs. 100000 and its paid up capital is Rs. 100000. It aspire to serve in METALS, CHEMICALS and PRODUCTS THEREOF MANUFACTURING activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on 0 and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 0.
SIRIPS PHARMA PRIVATE LIMITED has 2 directors SWATHI CHILUKALA, PRASAD GARREPALLY,
The registered Email address of SIRIPS PHARMA PRIVATE LIMITED is garrepallyprasad@gmail.com and its registered address is PLOT NO.12 RTC EXTENSION COLONY HAYATH NAGAR TELANGANA INDIA 501505 ANDHRA PRADESH ANDHRA PRADESH india 501505.
The current status of SIRIPS PHARMA PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
SIRIPS PHARMA PRIVATE LIMITED
HYDERABAD
ACTIVE
METALS, CHEMICALS and PRODUCTS THEREOF MANUFACTURING
U24233TG2015PTC098852
11 MAY 2015
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
100000
100000
CONTACT DETAILS
501505
INDIA
PLOT NO.12 RTC EXTENSION COLONY HAYATH NAGAR TELANGANA INDIA 501505
garrepallyprasad@gmail.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
07165073 | SWATHI CHILUKALA | Director | 11/05/2015 |
07165129 | PRASAD GARREPALLY | Director | 11/05/2015 |
Details Updated by Companies
Quick Links
- All Registered company of ANDHRA PRADESH
- Company Registered in ANDHRA PRADESH
- All Registered company of RANGAREDDY in ANDHRA PRADESH
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.